Sumalpong, Arselyn N.
HRN: 28-93-10 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/30/2026
CEFUROXIME 1.5GM (VIAL)
04/30/2026
05/07/2026
IV
1 Gm
Q8H
UTI
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: